• Molecular NameMetipranolol
  • SynonymMetipranolol hydrochloride; Metipranololum [INN-Latin]
  • Weight309.406
  • Drugbank_IDDB01214
  • ACS_NO22664-55-7
  • Show 3D model
  • LogP (experiment)2.28
  • LogP (predicted, AB/LogP v2.0)2.41
  • pkaN/A
  • LogD (pH=7, predicted)0.02
  • Solubility (experiment)0.589 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)0.08
  • LogSw (predicted, AB/LogsW2.0)7.07
  • Sw (mg/ml) (predicted, ACD/Labs)1.19
  • No.of HBond Donors2
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds8
  • TPSA67.79
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA non-selective beta blocker used in eye drops to treat glaucoma.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmThe beta-blocking agent metipranolol is very rapidly metabolized in vivo to yield deacetylmetipranolol, which has a non-selective beta-receptor blocking activity.
  • Half lifedesacetylmetipranolol 2~4 h but there is considerable intersubject variation.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)LD50=31 (intravenous)